Herbal natural products as a source of monoamine oxidase inhibitors: A review

Current Topics in Medicinal Chemistry

Volumn 12, Issue 20, 2012, Pages 2131-2144

  Delogu, Giovanna ^b   Viña, Dolores ^a   Serra, Silvia ^b   Lamela, Manuel ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Central nervous system; MAO A inhibitors; MAO B inhibitors; Natural products; Neuroprotection

Indexed keywords

ANEMARRHENA ASPHODELOIDES EXTRACT; ANTHOCYANIN; ANTIDEPRESSANT AGENT; ASPARAGUS RACEMOSUS EXTRACT; BETA CARBOLINE DERIVATIVE; COPTIS CHINENSIS EXTRACT; COUMARIN DERIVATIVE; CURCUMIN; DICHLOROMETHANE; EPIGALLOCATECHIN GALLATE; GINKGO BILOBA EXTRACT; GREEN TEA EXTRACT; HYPERICUM PERFORATUM EXTRACT; MELISSA OFFICINALIS EXTRACT; MONOAMINE OXIDASE A INHIBITOR; MONOAMINE OXIDASE B INHIBITOR; NATURAL PRODUCT; PIPERINE; PLANT EXTRACT; POLYPHENOL DERIVATIVE; QUERCETIN; RHAZYA STRICTA EXTRACT; SALVIA MILTIORRHIZA EXTRACT; SALVIA OFFICINALIS EXTRACT; SARSASAPOGENIN; SEROTONIN UPTAKE INHIBITOR;

ANTIOXIDANT ACTIVITY; ANXIETY; DIABETES MELLITUS; DRUG SCREENING; ENZYME ACTIVITY; HERBAL MEDICINE; HUMAN; HYPERTENSIVE CRISIS; HYPOTENSION; IC 50; IMMOBILIZATION; INSOMNIA; MAJOR DEPRESSION; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; PARKINSON DISEASE; REVIEW;

EID: 84874901744     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/156802612805219996     Document Type: Review

References (95)

1. Farnsworth, N.R.; Akerele, O.; Bingel, A.S.; Soejarto, D.D.; Guo, Z. Medicinal Plants in Therapy. Bull. of the World Health Organization, 1985, 63(6), 965-981.
2. Farnsworth N.R. In: Natural Products and Drug Development (Krogsgaard-Larsen, P.; Christensen, S.G.; Kofod H. Eds.) Munksgaard, Copenhagen, Dinamarca.1984; pp. 17-30.
3. Houghton, P.J.; Seth P. Plants and the central nervous system. Pharmacol. Biochem. Behav., 2003, 75, 501-512.
4. Tipton, K.F. Enzymology of monoamine oxidase. Cell. Biochem. Funct., 1986, 4, 79-87.
5. Dostert, P.; Strolin, B.M.; Jafre, M. Monoamine oxidase: basic and clinical frontiers. In Excerpta Medica; Elsevier: Amsterdan, 1982, pp. 197.
6. Singer T.P. In Chemistry and Biochemistry of Flavoenzymes; Muller, F., Ed.; CRC Press: Boca Raton FL, 1991; Vol. 2, pp. 437-470.
7. Ma, J.; Yoshimura, M.; Yamashita, E.; Nakagawa, A.; Ito, A.; Tsukihara, T. Structure of rat monoamine oxidase A and its specific recognitions for substrates and inhibitors. J. Mol. Biol., 2004, 338, 103-115.
8. Weyler, W.; Hsu Yun, P.P.; Breakefield, X.O. Biochemistry and genetics of monoamine oxidase. Pharmacol. Ther., 1990, 47, 391-417.
9. Drozak, J.; Kozlowski, M. Monoamine oxidase as a target for drug action. Postepy Hig. Med. Dosw., 2006, 60, 498-515.
10. Vindis, C.; Séguélas, M.H.; Bianchi, P.; Parini, A.; Cambon, C. Monoamine oxidase B induces ERK-dependent cell mitogenesis by hidrogen peroxide generation. Biochem. and Biophys. Res. Comm., 2000, 271, 181-185.
11. Thase, M.E.; Freiedman E.S.; Biggs M.M. Cognitive therapy versus medication in augmentation and switch strategies as secondstep treatments: a STAR*D report. Am. J. Psychiatry, 2007, 164, 739-752.
12. Youdim, M.B.; Edmondson, D.; Tipton K.F. The therapeutic potential of monoamine oxidase inhibitors. Nat. Rev. Neurosci., 2006, 7, 295-309.
13. Meyer, J.H.; Ginovart, N.; Boovariwala, A. Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression. Arch. Gen. Psychiatry, 2006, 63, 1209-1216.
14. Dittmann, K.; Gerhäuser, C.; Klimo, K.; Hamburger, M. HPLCBased activity profiling of Salvia miltiorrhiza for MAO A and iNOS inhibitory activities. Planta Med., 2004, 70, 909-913.
15. Zhou, C.X.; Kong, L.D.; Ye, W.C.; Cheng, C.H.K.; Tan, R.X. Inhibition of xanthine and monoamine oxidases by stilbenoids from Veratrum taliense. Planta Med., 2001, 67, 158-161.
16. Ren, L.X.; Luo, Y.F.; Li, X.; Zuo, D.Y.; Wu, Y.L. Antidepressantlike effects of Sarsasapogenin from Anemarrhena asphodeloides BUNGE (Liliaceae). Biol. Pharm. Bull., 2006, 29(11), 2304-2306.
17. Norton, S.A. Betel: Consumption and consequences. J. Am. Acad. Dermatol., 1998, 38, 81-88.
18. Dar, A.; Khatoon, S. Antidepressant activities of Areca catechu fruit extract. Phytomedicine, 1997, 4, 41-45.
19. Dar, A.; Khatoon, S. Behavioral and biochemical studies of dichloromethane fraction from Areca catechu Nut. Pharm. Biochem. Behavior, 2000, 65(1), 1-6.
20. Kulkarni, S.K.; Bhutani, M.K.; Bishnoi, M. Antidepressant activity of curcumin: involvement of serotonin and dopamine system. Psychopharm., 2008, 201, 435-442.
21. Kong, L.D.; Christopher, H.K.; Tan, R.X. Inhibition of MAO A and B by some plant-derived alkaloids, phenols and anthraquinones. J. Ethnopharmacol., 2004, 91, 351-355.
22. Meena, J.; Ojha, R.; Muruganandam, A.V.; Krishnamurthy, S. Asparagus racemosus competitively inhibits in vitro the acetylcholine and monoamine metabolizing enzymes. Neurosci. Lett., 2011, 503, 6-9.
23. Ali, B.H.; Bashir, A.K.; Tanira, M.O.M.; Medvedev, A.E.; Jarrett, N.; Sandler, M.; Glover, V. Effect of extract of Rhazya stricta, a traditional medicinal plant, on rat brain tribulin. Pharm. Biochem. Behavior, 1998, 59(3), 671-675.
24. Benvenga, M.J.; Leander, J.D. Antidepressant-like effect of LY228729 as measured in the rodent swim paradigm. Eur. J. Pharmacol., 1993, 239, 249-252.
25. Ali, B.H.; Bashir, A.K.; Tanira, M.O.M. The effect of Rhazya stricta Decne, a traditional medicinal plant, on the forced swimming test in rats. Pharm. Biochem. Behavior, 1998, 59(2), 547-550.
26. López, V.; Martín, S.; Gómez-Serranillos, M.P.; Carretero, M.E.; Jäger, A.K.; Calvo, M.I. Neuroprotective and neurological properties of Melissa officinalis. Neurochem. Res., 2009, 34, 1955-1961.
27. Mechan, A.O.; Fowler, A.; Seifert, N.; Rieger, H.; Wöhrle, T.; Etheve, S.; Wyss, A.; Schüler, G.; Colletto, B.; Kilpert, C.; Aston, J.; Elliott, J.M.; Goralczyk, R.; Mohajeri, M.H. Monoamine reuptake inhibition and mood-enhancing potential of a specified oregano extract. Br. J. Nutr., 2011, 105, 1150-1163.
28. Saaby, L.; Rasmussen, H.B.; Jäger, A.K. MAO-A inhibitory activity of quercetin from Calluna vulgaris (L.) Hull. J. Ethnopharmacol., 2009, 121, 178-181.
29. Gnerre, C.; von Poser, G.L.; Ferraz A.; Viana, A.; Testa, B.; Rates, S.M. Monoamine oxidase inhibitory activity of some Hypericum species native to South Brazil. J. Pharm. Pharmacol, 2001, 53(9), 1273-1279.
30. 11C]-harmine PET study. J. Psychiatry Neurosci., 2011, 36(6), 375-382.
31. Olsen, H.T.; Stafford, G.I.; van Staden, J.; Chistensen, S.B.; Jäger, A.K. Isolation of MAO-inhibitor naringenin from Mentha aquatica L. J.-Ethnopharmacol, 2008, 117, 500-502.
32. Pan, X.; Kong, L.D.; Zhang, Y.; Cheng, C.H.K.; Ren-Xiang, T. In vitro inhibition of rat monoamine oxidase by liquiritigenin and isoliquiritigenin isolated from Sinofranchetia chinensis. Acta Pharmacol. Sin., 2000, 21(10), 949-953.
33. Goulart, S.L. Contrastes e continuidades em uma tradição religiosa amazônica: os casos do Santo Daime, da Barquinha e UDV. In: Labate, B.C., Goulart, S.L. (Orgs.), O uso ritual das plantas de poder. Mercado de Letras, Campinas, 2005, pp. 355-396.
34. Herraiz, T.; González, D.; Ancín-Azpilicueta, C; Arán, V.J.; Guillén, H. β-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO). Food Chem. Toxicol., 2010, 48, 839-845.
35. von Bohlen und Halbach O., Schober A., Krieglstein K. Genes, proteins and neurotoxins involved in Parkinsońs disease. Prog. Neurobiol, 2004, 73, 151-177.
36. Youdim, M.B.; Bakhle, Y.S. Monoamine oxidase: isoforms and inhibitors in Parkinsońs disease and depressive illness. Br. J. Pharmacol, 2006, 147, 287-296.
37. Serrano-Dueñas, M.; Cardozo-Pelaez, F.; Sanchez-Ramos, J.R. Sci. Rev. Altern. Med., 2001, 5, 127-132.
38. Schwarz, M.J.; Houghton, P.J.; Rose, S.; Jenner, P.; Lees, AD. Activities of extract and constituents of Banisteriopsis caapi relevant to parkinsonism. Pharmacol, Biochem. Behav., 2003, 75, 627-633.
39. Samoylenko, V.; Rahman, Md. M.; Tekwani, B.L.; Trpathi, L.M.; Wang, Y.H.; Khan, S.I.; Khan, I.A.; Miller, L.S.; Joshi, V.C.; Muhammad, I. Banisteriopsis caapi, a unique combination of MAO inhibitory and antioxidative constituents for the activities relevant to neurodegenerative disorders and Parkinson's disease. J. Ethnopharmacol, 2010, 127, 357-367.
40. Herraiz, T.; Chaparro, C. Human monoamine oxidase enzyme inhibition by coffee and β-Carbolines norharman and harman isolated from coffee. Life Sci., 2006, 78, 795-802.
41. Ahmad, M.; Saleem, S.; Ahmad, A.S.; Seema, Y.; Ansari, M.A.; Khan, M.B.; Ishrat, T.; Chaturvedi, R.K.; Agrawal, A.K.; Islam, F. Ginkgo biloba affords dose-dependent protection against 6hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences. J. Neurochem., 2005, 93, 94-104.
42. Pardon, M.C.; Joubert, C; Perez-Díaz, F.; Christen, Y.; Launay, J.M.; Cohen-Salmon, C. In vivo regulation of cerebral monoamine oxidase activity in senescent controls and chronically stressed mice by long-term treatment with Ginkgo biloba extract (EGb 761). Mech. Ageing Dev., 2000, 113, 157-168.
43. Imanshahidi, M.; Hosseinzadeh, H. The pharmacological effects of Salvia species on the central nervous system. Phytother. Res., 2006, 20, 427-437.
44. Lin, R.D.; Hou, W.C.; Yen, K.Y.; Lee, M.H. Inhibition of monoamine oxidase B (MAO B) by Chinese herbal medicines. Phytomedicine, 2003, 10, 650-656.
45. Hou, W.C.; Lin, R.D.; Chen, C.T.; Lee, M.H. Monoamine oxidase B (MAO-B) inhibition by active principles from Uncaria rhynchophylla. J. Ethnopharmacol, 2005, 100, 216-220.
46. Levites, Y.; Weinreb, O.; Maor, G.; Youdim, M.B.H.; Mandel, S. Green tea polyphenol (-)-epigallocatechin-3-gallate prevents Nmethyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration. J. Neurochem., 2001, 78, 1073-1082.
47. Haraguchi, H.; Tanaka, Y.; Kabbash, A.; Fujioka, T.; Ishizu, T.; Yagi, A. Monoamine oxidase inhibitors from Gentiana lutea. Phytochemistry, 2004, 65, 2255-2260.
48. Carotti, A.; Carrieri, A.; Chimichi, S.; Boccalini, M.; Cosimelli, B.; Gnerre, C; Carotti, A.; Carrupt, P.A.; Testa, B. Natural and synthetic geiparvarins are strong and selective MAO-B inhibitors. Synthesis and SAR studies. Bioorg. Med. Chem. Lett., 2002, 12, 3551-3555.
49. Jeong, S.H.; Han, X.H.; Hong, S.S.; Hwang, J.S.; Hwang, J.H.; Lee, D.; Lee, M.K.; Ro, J.S.; Hwang, B.Y. Monoamine oxidase inhibitory coumarins from the aerial parts of Dictammus albus. Arch. Pharm. Res., 2006, 29(12), 1119-1124.
50. Hossain, C. F.; Okuyama, E.; Yamazaki, M. A new series of coumarin derivatives having monoamine oxidase inhibitory activity from Monascus anka. Chem. Pharm. Bull, 1996, 44(8), 1535-1539.
51. Han, Y.N.; Choo, Y.; Lee, Y.C.; Moon, Y.I.; Kim, S.D.; Choi, J.W. Monoamine oxidase B inhibitors from the fruits of Opuntia ficusindica var. saboten. Arch. Pharm. Res., 2001, 24(1), 51-54.
52. Castagnoli, K.P.; Steyn, S.J.; Petzer, P.; Van der Schyf, C.J.; Castagnoli, N. Neuroprotection in the MPTP parkinsonian C57BL/6 mouse model by a compound isolated from tobacco. Chem. Res. Tox., 2001, 14, 523-527.
53. Fowler, J.S.; Volkow, N.D.; Wang, G.J.; Pappas, N.; Logan, J.; Shea, C; Alexoff, D.; MacGregor, R.; Schlyer, D.; Zezulkova, I.; Wolf, A. P. Brain monoamine oxidase A inhibition in cigarette smokers. Proc. Natl. Acad. Sci. USA., 1996, 93, 14065-14069.
54. Fowler, J.S.; Volkow, N.D.; Wang, G.J.; Pappas, N.; Logan, J.; MacGregor, R.; Alexoff, D.; Shea, C; Schlyer, D.; Wolf, A.P. Inhibition of monoamine oxidase B in the brains of smokers. Nature, 1996, 379, 733-736.
55. Singh, Y.N.; Singh, N. Therapeutic potential of kava in the treatment of anxiety disorders. CNS Drugs, 2002, 16(1), 731-743.
56. Kong, L.D.; Cheng, C.H.K.; Tan, R.X. Monoamine oxidase inhibitors from rhizoma of Coptis chinensis. Planta Med. 2001, 67, 7476.
57. The Alkaloids: Chemistry and Pharmacology Edited by Geoffrey A. Cordell 1997, 49, 1-405.
58. Cao, R.; Peng, W.; Wang, Z.; Xu, A. β-Carboline alkaloids: biochemical and pharmacological functions. Curr. Med. Chem., 2007, 14, 479-500.
59. Handique, J.G.; Baruah, J.B. Polyphenolic compounds: an overview. React. Func. Polym., 2002, 52, 163-188.
60. Diermen, D.; Marston, A.; Bravo, J.; Reist, M.; Carrupt, P.A.; Hostettmann, K. Monoamine oxidase inhibition by Rhodiola rosea L. roots. J. Ethnopharmacol, 2009, 122, 397-401.
61. Grotewold E. The Science of Flavonoids, Springer, 2006.
62. Lee, M.H.; Lin, R.D.; Shen, L.Y.; Yang, L.L.; Yen, K.Y.; Hou, W.C. Monoamine oxidase B and free radical scavenging activities of natural flavonoids in Melastoma candidum D. Don. J. Agr. Food Chem., 2001, 49, 5551-5555.
63. Sloley B.D.; Urichuk L.J.; Morley P.; Durkin J.; Shan J.J.; Pang P.K.T.; Coutts R.T. Identification of Kaempferol as a monoamine oxidase inhibitor and potential neuroprotectant in extracts of Ginkgo Biloba leaves. J. Pharm. Pharmacol, 2000, 52, 451-459.
64. Gnerre, C; Thull, U.; Gaillard, P.; Carrupt, P.A.; Testa, B.; Fernandes, E.; Silva, F.; Pinto, M.; Pinto, M.M.M.; Wolfender, J.L.; Hostettmann, K.; Cruciani, G. Natural and synthetic xanthones as monoamine oxidase inhibitors, biological assay and 3D-QSAR. Helv. Chim. Acta, 2001, 84, 552-570.
65. Chimenti, F.; Cottiglia, F.; Bonsignore, L.; Casu, M.; Floris, C; Secci, D.; Bolasco, A.; Chimenti, P.; Granese, A.; Befani, O.; Turini, P.; Alcaro, S.; Ortuso, F.; Trombetta, G.; Loizzo, A.; Guarino I. Quercetin as the active principle of Hypericum hircinum exerts a selective inhibitory activity against MAO-A: extraction, biological analysis, and computational study. J. Nat. Prod., 2006, 69, 945-949.
66. Han, X.H.; Hong, S.S.; Hwang, J.S.; Lee, M.K.; Hwang, B.Y.; Ro, J.S. Monoamine oxidase inhibitory components from Carytia japonica. Arch. Pharm. Res., 2007, 30, 13-17.
67. Deng, S.; West, B.J. Antidepressant effects of Noni fruit and its active principals. Asian J. Med. Sci., 2011, 3, 79-83.
68. Hwang, J.S.; Lee, S.A.; Hong, S.S.; Lee, K.S.; Lee, M.K.; Hwang, B.Y.; Ro, J.S. Monoamine oxidase inhibitory components from the roots of Sophora flavescens. Arch. Pharmacal. Res., 2005, 28, 190-194.
69. Desideri, N.; Bolasco, A.; Fioravanti, R.; Proietti Monaco, L.; Orallo, F.; Yañez, M.; Ortuso, F.; Alcaro, S. Homoisoflavonoids: natural scaffolds with potent and selective monoamine oxidase-B inhibition properties J. Med. Chem., 2011, 54, 2155-2164.
70. Asada, T.; Tamura, H. Isolation of anthocyanidin 3-glycosides bearing ortho-dihydroxyl groups on the b-ring by forming an aluminium complex, and their antioxidant activity. J. Agric. Food Chem. Doi: 10.1021/jf302476n
71. Dreiseitel, A.; Korte, G.; Schereir, P.; Oehme, A.; Locher, S.; Domani, M.; Hajak, G.; Sand, P.G. Berry anthocyanins and their aglycons inhibit monoamine oxidases A and B. Pharmacol. Res., 2009, 59, 306-311.
72. Go, M.L.; Wu, X.; Liu, X.L. Chalcones: an update on cytotoxic and chemoprotective properties. Curr. Med. Chem., 2005, 12, 481-499.
73. Chimenti, F.; Fioravanti, R.; Bolasco, A.; Chimenti, P.; Secci, D.; Rossi, F.; Yañez, M.; Orallo, F.; Ortuso, F.; Alcaro, S. Chalcones: A valid scaffold for monoamine oxidases inhibitors. J. Med. Chem., 2009, 52, 2818-2824.
74. Pedraza-Chaverri, J.; Cárdenas-Rodríguez, N.; Orozco-Ibarra, M.; Pérez-Rojas, J.M. Medicinal properties of mangosteen (Garcinia mangostana). Food Chem. Toxicol., 2008, 46, 3227-3239.
75. Suzuki, O.; Katsumata, Y.; Oya, M.; Chari, V.M.; Vermes, B.; Wagner, H.; Hostettmann, K. Inhibition of type A and type B monoamine oxidases by naturally occurring xanthones. Planta Med., 1981, 42, 17-21.
76. Hostettmann, K.; Hostettmann, M. Methods In Plant Biochemistry, Ed. Y. B. Harborne, Academic Press, New York, 1989, 493-508.
77. Dimitrov, M.; Nikolova, I.; Benbasat, N.; Kitanov, G.; Danchev, N. Acute toxicity, antidepressive and MAO inhibitory activity of mangiferin isolated from Hypericum aucheri. Biotechnol. & Biotechnol. Eq., 2011, 25, 2668-2671.
78. Bruhlmann, C; Marston, A; Hostettmann, K.; Carrupt, P.A.; Testa, B. Screening of non-alkaloidal natural compounds as acetyl cholinesterase inhibitors. Chem. Biodivers., 2004, 1, 819-829.
79. Thull, U.; Kneubühler, S.; Testa, B.; Borges, M.F.M.; Pinto, M.M.M. Substituted xanthones as selective and reversible monoamine oxidase A (MAO-A) inhibitors. Pharm. Res., 1993, 10, 1187-1190.
80. Chimenti, F.; Secci, D.; Bolasco, A.; Chimenti, P.; Bizzarri, B.; Granese, A.; Carradori, S.; Yanez, M.; Orallo, F.; Ortuso, F.; Alcaro, S. Synthesis, molecular modeling, and selective inhibitory activity against human Monoamine Oxidases of 3-carboxamido-7substituted coumarins. J. Med. Chem., 2009, 52, 1935-1942.
81. Matos, M.J.; Terán, C; Pérez-Castillo, Y.; Uriarte, E.; Santana, L.; Viña, D. Synthesis and study of a series of 3-arylcoumarins as potent and selective Monoamine Oxidase B inhibitors. J. Med. Chem., 2011, 54, 7127-7137.
82. Viña, D.; Matos, M.J.; Yáñez, M.; Santana, L.; Uriarte, E. 3Substituted coumarins as dual inhibitors of AChE and MAO for the treatment of Alzheimer's disease. Med. Chem. Comm., 2011, 3, 213-218.
83. Delogu, G.; Picciau, C; Ferino, G.; Quezada, E.; Podda, G.; Uriarte, E.; Viña, D. Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives. Eur. J. Med. Chem., 2011, 49, 1147-1152.
84. Serra, S.; Ferino, G.; Matos, M.J.; Vázquez-Rodríguez, S.; Delogu, G.; Viña, D.; Cadoni, E.; Santana, L.; Uriarte, E. Hydroxycoumarins related to isoflavones as MAO-B selective inhibitors. Bioorg. Med. Chem. Lett., 2012, 22, 258-261.
85. Carotti, A.; Altomare, C; Catto, M.; Gnerre, C; Summo, L.; De Marco, A.; Rose, S.; Jenner, P.; Testa, B. Lipophilicity plays a major role in modulating the inhibition of monoamine oxidase B by 7-substituted coumarins. Chem. Biodivers., 2006, 3, 134-149.
86. Jo, Y.S.; Huong, D.T.L.; Bae, K.; Lee, M.K.; Kim, Y.H. Monoamine oxidase inhibitory coumarin from Zanthoxylum schinifolium. Planta Med., 2002, 68, 84-85.
87. Kong, L.D.; Tan, R.X.; Woo, A. Y.H.; Cheng, C.H.K. Inhibition of rat brain monoamine oxidase activities by psoralen and isopsoralen: implications for the treatment of affective disorders. Pharmacol. Toxicol., 2001, 88, 75-80.
88. Larok, R.C.; Han, X.; Doty, M.J. Synthesis of a-pyrones via Palladium-catalyzed annulation of internal alkyne. Tetrahedron Lett., 1998, 39, 5713-5716.
89. Dickinson, J.M. Microbial pyran-2-ones and dihydropyran-2-ones. Nat. Prod. Rep., 1993, 10, 71-98.
90. Uebelhack, R.; Franke, L.; Schewe, H.J. Inhibition of platelet MAO-B by Kava pyrone-enriched extract from Piper Methisticum Forster (Kava Kava). Pharmacopsychiat. 1998, 31, 187-192.
91. Zhang, H.; Qiu, M.; Chen, Y.; Chen, J.; Sun, Y.; Wang, C; Fong, H.H.S. Plant Terpenes. Phytochemistry and Pharmacognosy. Encyclopedia of Lyfe Support Systems, 2002.
92. Diermen, D.; Marston, A.; Bravo, J.; Reist, M.; Carrupt, P.A.; Hostettmann, K. Monoamine oxidase inhibition by Rhodiola rosea L. roots. J. Ethnopharmacol, 2009, 122, 397-401.
93. Hamburger, M.; Hostettmann, K. Bioactivity in plants: the link between phytochemistry and medicine. Phytochemistry, 1991, 30, 3864-3874.
94. Dittmann K.; Riese U.; Hamburger, M. HPLC-based bioactivity profile of plant extracts: a kinetic assay for the identification of monamine oxidase-A inhibitors using human recombinant monoamine oxidase-A. Phytochemistry, 2004, 2885-2891.
95. Lichun Zhang, K.H.; Shulin Zhao, X.L. Rapid screening of monoamine oxidase B inhibitors in natural extracts by capillary electrophoresis after enzymatic reaction at capillary inlet. J. Chromatog.B., 2010, 878, 3156-3160.